These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 894487)

  • 1. Nonlinear relationship between plasma and red blood cell pharmacokinetics of chlorthalidone in man.
    Fleuren HL; van Rossum JM
    J Pharmacokinet Biopharm; 1977 Aug; 5(4):359-75. PubMed ID: 894487
    [No Abstract]   [Full Text] [Related]  

  • 2. Interindividual differences in chlorthalidone concentration in plasma and red cells of man after single and multiple doses.
    Collste P; Garle M; Rawlins MD; Sjöqvist F
    Eur J Clin Pharmacol; 1976 Feb; 9(4):319-25. PubMed ID: 971715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and sensitive determination of chlorthalidone in blood, plasma and urine of man using high-performance liquid chromatography.
    Guelen PJ; Baars AM; Vree TB; Nijkerk AJ; Vermeer JM
    J Chromatogr; 1980 Mar; 181(3-4):497-503. PubMed ID: 7391165
    [No Abstract]   [Full Text] [Related]  

  • 4. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
    Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
    Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent urinary excretion of chlorthalidone.
    Fleuren HL; Verwey-van Wissen C; van Rossum JM
    Clin Pharmacol Ther; 1979 Jun; 25(6):806-12. PubMed ID: 445947
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of chlorthalidone in plasma, urine and red blood cells by gas chromatography with nitrogen detection.
    Fleuren HL; Van Rossum JM
    J Chromatogr; 1978 May; 152(1):41-54. PubMed ID: 649750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chlorthalidone pharmacodynamics in beagle dogs.
    MacGregor TR; Keirns JJ; Farina PR; Matzek KM; Horhota ST; Esber HJ
    J Pharm Sci; 1985 Aug; 74(8):851-6. PubMed ID: 4032269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of chlorthalidone. Dependence of biological half life on blood carbonic anhydrase levels.
    Mulley BA; Parr GD; Rye RM
    Eur J Clin Pharmacol; 1980; 17(3):203-7. PubMed ID: 6767611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of carbonic anhydrase binding on the pharmacokinetics of chlorthalidone [proceedings].
    Parr GD; Mulley BA; Rye RM
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():42P. PubMed ID: 42717
    [No Abstract]   [Full Text] [Related]  

  • 10. Analysis of chlorthalidone in biological fluids by high-performance liquid chromatography using a rapid column cleanup procedure.
    MacGregor TR; Farina PR; Hagopian M; Hay N; Esber HJ; Keirns JJ
    Ther Drug Monit; 1984; 6(1):83-90. PubMed ID: 6710559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic studies with chlorthalidone (Hygroton) in man.
    Riess W; Dubach UC; Burckhardt D; Theobald W; Vuillard P; Zimmerli M
    Eur J Clin Pharmacol; 1977 Dec; 12(5):375-82. PubMed ID: 598410
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding-site interaction of chlorthalidone and acetazolamide, two drugs transported by red blood cells.
    Beermann B; Hellström K; Lindström B; Rosén A
    Clin Pharmacol Ther; 1975 Apr; 17(4):424-32. PubMed ID: 804371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of chlorthalidone in whole blood by high-performance liquid chromatography.
    Rosenberg MJ; Lam KK; Dorsey TE
    J Chromatogr; 1986 Mar; 375(2):438-43. PubMed ID: 3700570
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous determination of atenolol and chlorthalidone in plasma by high-performance liquid chromatography. Application to pharmacokinetic studies in man.
    Giachetti C; Tenconi A; Canali S; Zanolo G
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):187-94. PubMed ID: 9367207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative bioavailability of chlorthalidone in humans after single oral doses.
    Farina PR; MacGregor TR; Horhota ST; Keirns JJ
    J Pharm Sci; 1985 Sep; 74(9):995-8. PubMed ID: 4067856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved method for estimating chlorthalidone in body fluids.
    Tweeddale MG; Ogilvie RI
    J Pharm Sci; 1974 Jul; 63(7):1065-8. PubMed ID: 4852369
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of competitive red blood cell binding and reduced hematocrit on the blood and plasma levels of [14C]Indapamide in the rat.
    Lettieri JT; Portelli ST
    J Pharmacol Exp Ther; 1983 Feb; 224(2):269-72. PubMed ID: 6822954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy compliance and plasma potassium level in patients treated with chlorthalidone].
    van Kalmthout PM; Vree TB; Thien T
    Ned Tijdschr Geneeskd; 1983 Jan; 127(5):192-5. PubMed ID: 6828190
    [No Abstract]   [Full Text] [Related]  

  • 19. Automated analysis of chlorthalidone.
    Johnston MM; Rosenberg M; Kamath B
    J Pharm Sci; 1979 Aug; 68(8):967-70. PubMed ID: 480175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of chlorthalidone in human plasma by reversed-phase micellar liquid chromatography.
    Dadgar D; Kelly MT
    Analyst; 1988 Aug; 113(8):1223-7. PubMed ID: 3232833
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.